Real-time enrollment status for this solid tumors clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 8:34 AM UTC
| NCT Number | NCT06979596 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumors |
| Phase | PHASE2 |
| Target Enrollment | 250 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | July 17, 2026 (3 days ago) |
As of July 20, 2026: Clinical trial NCT06979596 is currently recruiting participants. This phase2 study for solid tumors is actively seeking new participants at 10 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06979596 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06979596 was last updated 3 days ago (July 17, 2026). HelloStudys verifies this status automatically.